
Intellia Therapeutics has announced a pause in two of its advanced CRISPR gene-editing clinical trials after a patient involved in one trial experienced liver damage that required hospitalization.

Explore the latest trends and developments from nearly three decades of IVF treatments in the United Kingdom. Also, catch up on other important health updates featured in the Morning Rounds newsletter.

Intellia Therapeutics is confronting a major survival challenge after its CRISPR gene-editing treatment was linked to severe, potentially fatal liver toxicity, raising serious safety concerns.

Researchers express concern that decisions about Medicaid home care eligibility often lack public transparency and may prioritize cost over actual health needs. Eligibility algorithms differ significantly across states, leading to inconsistent access to care.

Experts clarify how specific study designs can distinguish true cause-and-effect relationships from mere correlations.

The premier European oncological association has published its inaugural guidelines on the appropriate usage of large language models by its members in clinical settings.

Eric Kauderer-Abrams, head of biology at Anthropic, shares insights into the company's innovative use of AI for life sciences. He highlights the unique approach Anthropic takes with its language models and explains why scientists can have confidence in these large language models (LLMs) for advancing research and discovery in life sciences.

A crucial insight from the past five years is the urgent need for public health to improve its approach to managing uncertainty.

Trust in public health institutions has been waning over the years. Popular YouTuber Doctor Mike proposes new strategies to enhance social media engagement and restore public confidence in healthcare.

The American Medical Association (AMA) has unveiled a new Center for Digital Health and AI. AMA CEO John Whyte provides insights into the center's mission and goals in a recently published Q&A.